1-888-210-3553

1-888-210-3553

The Potential of Psychedelics for the Treatment of Episodic Migraine

Purpose of Review

This review presents the existing literature of and a framework for how psychedelic drugs might be applied as therapeutic agents in episodic migraine.

 

Recent Findings

The therapeutic effects of psychedelics in headache disorders have been reported for decades and controlled investigations are now beginning. In the first and only clinical trial of a psychedelic drug in migraine, the single administration of low-dose psilocybin reduced weekly migraine days and pain intensity for the following 2 weeks in episodic subjects. These transitional effects, along with abortive effects in two subjects and additional findings in cluster headache, offer insight into the potential medicinal use of this and other psychedelic drugs in episodic migraine.

 

Summary

The existing evidence supports the continued investigation of psilocybin and other psychedelics as transitional treatments in episodic migraine. Acute and preventive effects also exist, but the risks may outweigh benefits with these applications. Future research of psychedelics in episodic migraine should be tailored for this condition and not modeled after protocols used in other medical or psychiatric conditions.

Stay Updated On Psychedelic News

Join our newsletter to receive updates about the latest psychedelic news, hear about our ground-breaking research, and learn what we think about the latest trends shaping the future of psychedelics.

Planning Your Psychedelic Trip?
Our Info Line Can Help.

We provide 100% free, 1:1 guidance for anyone preparing for a psychedelic experience. Learn more about our evidence-based approach or book a call today.

Learn MoreBook a Call

Pop-ups are annoying, but our emails aren't!

We hate pop-ups as much as you do, but if you want to stay up to date about the latest news in the psychedelic space and learn about our ground-breaking psychedelic research, please consider signing up for our newsletter below.